Effect of cardiopulmonary bypass on urea cycle intermediates and nitric oxide levels after congenital heart surgery.

OBJECTIVE To test the hypothesis that cardiopulmonary bypass used for repair of ventricular septal defects and atrioventricular septal defects would decrease availability of urea cycle intermediates including arginine and subsequent nitric oxide availability. STUDY DESIGN Consecutive infants (n = 26) undergoing cardiopulmonary bypass for repair of an unrestrictive ventricular septal defect or atrioventricular septal defect were studied. Blood samples were collected immediately before surgery, immediately after surgery, and 12 hours, 24 hours, and 48 hours after surgery. Urea cycle intermediates, including citrulline, arginine, and ornithine, were measured by amino acid analysis. Nitric oxide metabolites were measured by means of the modified Griess reaction. RESULTS Cardiopulmonary bypass caused a significant decrease in the urea cycle intermediates arginine, citrulline, and ornithine at all postoperative time points compared with preoperative levels. The ratio of ornithine to citrulline, a marker of urea cycle function, was elevated at all postoperative time points compared with preoperative values, indicating decreased urea cycle function. Nitric oxide metabolites were significantly decreased at all postoperative time points except for 48 hours, compared with preoperative levels. CONCLUSIONS Cardiopulmonary bypass significantly decreases availability of arginine, citrulline, and nitric oxide metabolites in the postoperative period. Decreased availability of nitric oxide precursors may contribute to the increased risk of postoperative pulmonary hypertension.

[1]  M. Summar.  Molecular genetic research into carbamoyl-phosphate synthase I: Molecular defects and linkage markers , 1998, Journal of Inherited Metabolic Disease.

[2]  J. Freeman,et al.  Acute pulmonary hypertension complicating the arterial switch procedure , 1995, Pediatric Cardiology.

[3]  W F Walsh,et al.  Neonatal pulmonary hypertension--urea-cycle intermediates, nitric oxide production, and carbamoyl-phosphate synthetase function. , 2001, The New England journal of medicine.

[4]  A. Redington,et al.  Pulmonary vascular resistance after cardiopulmonary bypass in infants: effect on postoperative recovery. , 2001, The Journal of thoracic and cardiovascular surgery.

[5]  R. Steinhorn,et al.  The pathophysiology of pulmonary hypertension in congenital heart disease. , 1999, Artificial organs.

[6]  D. Gozal,et al.  Pulmonary risk factors compromising postoperative recovery after surgical repair for congenital heart disease. , 1999, Chest.

[7]  S. Kerber,et al.  Reevaluation of the Griess method for determining NO/NO2- in aqueous and protein-containing samples. , 1999, Nitric oxide : biology and chemistry.

[8]  D. McElhinney,et al.  Early results of the extracardiac conduit Fontan operation. , 1999, The Journal of thoracic and cardiovascular surgery.

[9]  A. Redington,et al.  L-arginine and substance P reverse the pulmonary endothelial dysfunction caused by congenital heart surgery , 1999, Circulation.

[10]  S. Takamoto,et al.  Cardiac surgery and inhaled nitric oxide: indication and follow-up (2-4 years). , 1998, Artificial organs.

[11]  W. Williams,et al.  Mortality in potential arterial switch candidates with transposition of the great arteries. , 1998, Journal of the American College of Cardiology.

[12]  N. Silverman,et al.  The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. , 1998 .

[13]  B. Rigler,et al.  Inhaled nitric oxide in infants and children after open heart surgery. , 1998, Journal of Cardiovascular Surgery.

[14]  M. South,et al.  Altered activation of the L-arginine nitric oxide pathway during and after cardiopulmonary bypass , 1997, Perfusion.

[15]  A. Serraf,et al.  Endogenous nitric oxide production and atrial natriuretic peptide biological activity in infants undergoing cardiac operations. , 1997, Critical care medicine.

[16]  B. Rigler,et al.  Inhaled nitric oxide in patients with critical pulmonary perfusion after Fontan-type procedures and bidirectional Glenn anastomosis. , 1997, The Journal of thoracic and cardiovascular surgery.

[17]  R. Jonas,et al.  Diagnostic use of inhaled nitric oxide after neonatal cardiac operations. , 1996, Journal of Thoracic and Cardiovascular Surgery.

[18]  P. Kirshbom,et al.  Effects of cardiopulmonary bypass and circulatory arrest on endothelium-dependent vasodilation in the lung. , 1996, The Journal of thoracic and cardiovascular surgery.

[19]  G. Luciani,et al.  Surgical repair of transposition of the great arteries in neonates with persistent pulmonary hypertension. , 1996, Annals of Thoracic Surgery.

[20]  S. Moncada,et al.  The L-arginine-nitric oxide pathway. , 1993, The New England journal of medicine.

[21]  V. Rubio.  Structure-function studies in carbamoyl phosphate synthetases. , 1993, Biochemical Society transactions.

[22]  S. Moncada,et al.  L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. , 1988, Biochemical and biophysical research communications.

[23]  S. Tannenbaum,et al.  Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. , 1982, Analytical biochemistry.

[24]  N. Räihä,et al.  DEVELOPMENT OF UREA‐SYNTHESIZING ENZYMES IN HUMAN LIVER , 1968, Acta paediatrica Scandinavica.